4
Changes in Ownership
NeuroSense Therapeutics Ltd. Filed Acc 0001213900-26-069662
Chief Financial Officer bought 250,000 shares at $0.80 ($200,000)
From the SEC's structured data for this filing
Trades in this filing
Eisenberg Or · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-16 | Purchase : show line 1 in the form | +250,000 | $0.80 | $200,000 | 1,504,050 | D |
| Open-market purchases · 250,000 sh · avg $0.80 · $200,000 | ||||||
Loading xslF345X06/ownership.xml…